YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Cancer Sci
; 114(11): 4299-4313, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37700438
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gallbladder Neoplasms
/
Gemcitabine
Limits:
Humans
Language:
En
Journal:
Cancer Sci
Year:
2023
Document type:
Article
Affiliation country:
China